Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
This intro contrasts SP 500 with target date funds, highlighting flexibility, fees, and potential growth paths relevant to retirement planning.
27,405 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
February market action favors growth names as earnings beat and cash flow strengthens. This report highlights three h...
The iShares MSCI South Korea ETF has surged on AI memory demand, with Samsung Electronics and SK Hynix driving a hidd...
A misread of the social security earnings test could cost retirees thousands in benefits. Two thresholds and smart ti...
An insider move can send shockwaves through a stock, but it isn't a crystal ball. This guide explains what theFork CE...
Tech giants are investing heavily in AI, yet leaders warn that compute costs may outstrip wages. New MIT findings and...
The SEC approves WisdomTree's request for exemptive relief, unlocking 24/7 trading and near-instant settlement for to...
A wedding venue owner took more than $1 million from unsuspecting couples and investors. This article uncovers how th...
SpaceX joins the Nasdaq-100, setting up a mechanical buy flow for index funds. Analysts estimate about $4.3 billion i...
Interpol links a crypto wallet tied 20-year-old to $122.5 million moved in 10 months, prompting a worldwide push agai...
A bold new era in investing is here. This deep dive explores Jason Wenk’s journey, Altruist’s AI-driven custody model...
The VanEck BDC Income ETF offers a high 13% quarterly yield by investing in business development companies. Yet the f...